Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

SPSB vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, SPSB returned +2.2% to XBI's +41.2%, and SPSB charges 0.04% to XBI's 0.35%.

askIQ about this page

askIQ about SPSB and XBI

Net assets on Oct 27, 2026: $11.3bn for State Street SPDR Portfolio Short Term Corporate Bond ETF and $10.3bn for State Street SPDR S&P Biotech ETF.

At a glance
+2.2%
SPSB total return, 1 year
+41.2%
XBI total return, 1 year
0.04%
SPSB expense ratio
0.35%
XBI expense ratio

Pair scorecard

SPSB costs 0.31 points a year less; their one-year returns differ by 39.0 points; SPSB is 1.1 times larger.

SPSB vs XBI: Differences, Returns & Fees
MeasureSPSBXBI
Return
Total return, 1 year+2.2%+41.2%
Drawdown
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksBloomberg U.S. 1-3 Year Corporate Bond IndexBiotech
Cost and size
Expense ratio0.04%0.35%
Net assets, as of Oct 27, 2026$11.3bn$10.3bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
In the S&P 500, by weight13%
Top ten holdings, share of the fund18%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, SPSB and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first SPSB XBI
Only in one fund ↓
Only in SPSB
SALESFORCE INC SR UNSECURED 03/29 4.65 0.66%
AERCAP IRELAND CAP/GLOBA COMPANY GUAR 10/28 3 0.47%
PFIZER INVESTMENT ENTER COMPANY GUAR 05/28 4.45 0.45%
AMAZON.COM INC SR UNSECURED 03/29 4 0.45%
BANK OF AMERICA CORP SR UNSECURED 12/28 VAR 0.45%
NVIDIA CORP SR UNSECURED 06/29 4.35 0.43%
GOLDMAN SACHS GROUP INC SR UNSECURED 05/29 VAR 0.38%
ORACLE CORP SR UNSECURED 02/29 4.55 0.37%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

SPSB State Street SPDR Portfolio Short Term Corporate Bond ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of Short Term Corporate Bond Biotech
Total return, 1 year +2.2% +41.2%
Its benchmark over the same days −1.4% (AGG) not measured
Gap to its benchmark +3.6 pts vs AGG not measured
Expense ratio 0.04% 0.35%
Holdings 1684 165
Net assets, as of Oct 27, 2026 $11.3bn $10.3bn

SPSB and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

SPSB and XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
SPSB

SPSB tracks an index of Short Term Corporate Bond. Over the year to Oct 28, 2026 it returned +2.2% with distributions reinvested, against −1.4% for its benchmark, the Bloomberg U.S. Aggregate Bond Index. The prospectus expense ratio is 0.04% a year.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are SPSB and XBI in the same category?
SPSB is a bond ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, SPSB or XBI?
In the year to Oct 28, 2026, with distributions reinvested, SPSB returned +2.2% and XBI +41.2%.
Which is cheaper, SPSB or XBI?
SPSB is cheaper, by 0.31 percentage points a year. That is about $31 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, SPSB against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/spsb-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.